CannabisNewsBreaks

TuesdayMar 27, 2018 9:24 am

CBDNewsBreaks – Marijuana Company of America, Inc. (MCOA) Engages Marketing Company to Launch hempSMART Retail Marketing Campaign

Marijuana Company of America (OTC: MCOA) this morning said that it has engaged Eddy Pham & Company (“EPCO”) to provide retail marketing and advertising services for its hempSMART™ branded products. EPCO, a direct to consumer full-service marketing company, is poised to help hempSMART products be successful through providing a fully integrated, multi-channel transactional marketing campaign comprised of digital advertising, infographics, content marketing, customer incentives and acquisition, a broad social media presence as well as search engine marketing and optimization that includes full research and analytics. "MCOA is honored to have EPCO on as a marketing partner for our hempSMART product…

Continue Reading

MondayMar 26, 2018 3:35 pm

CBDNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Prepares to Pounce on Canada’s Recreational Cannabis Market Following Upcoming Legalization

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is currently planning its expansion strategy as the end of cannabis prohibition in Canada approaches. An article discussing the company reads: “According to the company’s investor presentation made in November, by 2021, the recreational marijuana industry that Choom™ Holdings exclusively aims to serve is expected to be almost eight times the size of the medical marijuana industry, which is served by Choom’s Medi-Can Health Solutions Ltd. subsidiary, with benefits spilling over into the tourism industry, governmental tax and licensing coffers, and paraphernalia manufacturing market. Its nimble business model…

Continue Reading

MondayMar 26, 2018 3:24 pm

CBDNewsBreaks – Namaste Technologies, Inc. (CSE: N) (FRA: M5BQ) (OTC: NXTTF) Subsidiary Inks Medical Cannabis Supply Agreement with Clever Leaves

Namaste Technologies (CSE: N) (FRA: M5BQ) (OTC: NXTTF), through its wholly-owned subsidiary Cannmart Inc., has signed a medical cannabis product acquisition agreement with medical cannabis producer Clever Leaves with the assistance of Clever Leaves’ financial sponsor, Northern Swan Holdings, Inc. Clever Leaves is a vertically integrated, licensed producer of medical cannabis in Colombia that recently commenced construction of a 15+ hectare good agricultural collection practices compliant cultivation facility and Good Manufacturing Practices (“GMP”) Level-2 Extraction facility. Per the terms of the agreement, Cannmart will submit purchase orders to Clever Leaves for medical cannabis. Subject to approval by Health Canada, Cannmart…

Continue Reading

MondayMar 26, 2018 10:19 am

CBDNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Set to Provide Business Updates While Sponsoring at the 2018 NIBA Meeting

Market analysis company ChineseInvestors.com (OTCQB: CIIX) this morning said it will sponsor at the 2018 National Investment Bankers Association ("NIBA") meeting in New York City at the Westin Hotel in Times Square on March 27, 2018. Warren Wang, the company’s CEO, will provide a video interview highlighting the company's business updates that will be available for viewing on NIBA's website. The video interview will include details regarding the company’s new cryptocurrency focused website, its recently entered partnership with Phoenix North America Chinese Channel, and its strategy regarding the company's investor relations service which aims to meet specific marketing objectives. "CIIX…

Continue Reading

MondayMar 26, 2018 9:58 am

CBDNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary’s MediPets Line Garners Interest at the Global Pet Expo

PotNetwork Holding, Inc. (OTC: POTN), through wholly owned subsidiary Diamond CBD, Inc., this morning announced promising results related to its attendance at the 2018 Global Pet Expo in Orlando, Florida. In total, the company estimates that it garnered interest from over 200 new wholesale distributors that are well suited to carry its groundbreaking CBD-for-pets product line, MediPets. “Our new MediPets line is specifically designed to manage a wide variety of symptoms in their pets with reportedly effective, non-toxic, hemp-derived cannabinoids,” Richard Goulding, CEO of PotNetwork Holding, stated in the news release. “We are pleased to be experiencing this level of…

Continue Reading

MondayMar 26, 2018 9:28 am

CBDNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Completes Integration of California Subsidiary

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has successfully completed the integration of its California subsidiary, ERS Holdings Ltd., under the guidance of Patrick Rolfes, president of Pivot Pharmaceuticals USA. Per the update, Pivot is currently preparing for a 2018 product launch in California, with a consumer-facing brand scheduled to be unveiled in the coming weeks. “As the Company prepares for legalization of cannabis in Canada, we continue to expand our business operations in the US market on a state-by-state basis, where regulations permit,” Dr. Patrick Frankham, Pivot CEO, stated…

Continue Reading

FridayMar 23, 2018 3:47 pm

CBDNewsBreaks – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) Inks Partnership Agreement with Kawacatoose First Nation

Isodiol International (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, recently announced that it has signed a partnership agreement with Kawacatoose First Nation (“KFN”). The two companies will collaborate to cultivate and manufacture high yielding CBD derived from industrial hemp. The companies also intend to explore additional economic opportunities in commercializing the hemp by-product into everyday finished goods. Per the terms of the agreement, KFN will provide up to 3,000 farmable acres of land, based on availability and subject to certain conditions being met by both parties on…

Continue Reading

FridayMar 23, 2018 12:16 pm

CBDNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Capitalizing on the Vast Market Potential of Hemp, CBD Products

Hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) remains primarily focused on the cultivation of hemp and cannabinoid extraction for both domestic and international markets. An article discussing the company reads: “Founded in 2014, Global Hemp Group is building a strategic portfolio of hemp-based companies to provide its global customer base with a consistent supply of high-quality hemp-derived products. It intends to leverage the huge market potential of hemp products to deliver significant ROI to its shareholders. The number of products that can be manufactured from the hemp plant is vast. It can be used to…

Continue Reading

FridayMar 23, 2018 12:09 pm

CBDNewsBreaks – Marijuana Company of America, Inc. (MCOA) Offers a Natural Option for Pet Owners with hempSMART Full Spectrum Pet Drops

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) recently launched its new CBD-based natural pet product, hempSMART™ Full Spectrum Pet Drops. An article discussing the company’s new pet product line reads: “MCOA’s hempSMART™ Full Spectrum Pet Drops for cats and dogs are formulated with 250mg of full spectrum non-psychoactive cannabidiol (CBD) derived from industrial hemp. The new, specially-formulated product contains naturally-occurring CBD derived from hemp seed oil, full spectrum hemp extract, fractionated coconut oil and a rich bacon flavor that pets will love. The new Full Spectrum Pet Drops add a new vertical to MCOA’s fast growing…

Continue Reading

FridayMar 23, 2018 11:22 am

CBDNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Technology Mimics the Body’s Natural Creation of Pain Fighting Peptides

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is engaged in the development of pain relievers that mimic body’s natural pain relief peptides. An article discussing the company reads: “The linker technology that underlies PreveCeutical’s drug development platform was developed at the University of Queensland in Australia. At that impressive institution, Dr. Parekh headed a team that developed synthetic molecules capable of mimicking the endomorphins produced by the body for pain relief, as explained by PreveCeutical chairman and CEO Stephen Van Deventer in a recent video interview (http://cnw.fm/fEO5a). Although they are as potent as morphine, the effect…

Continue Reading